Cargando…
Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765479/ http://dx.doi.org/10.1186/1475-2840-12-120 |
| _version_ | 1782283318939615232 |
|---|---|
| author | van Ark, Joris Hammes, Hans-Peter van Dijk, Marcory CRF Lexis, Chris PH van der Horst, Iwan CC Zeebregts, Clark J Vervloet, Marc G Wolffenbuttel, Bruce HR van Goor, Harry Hillebrands, Jan-Luuk |
| author_facet | van Ark, Joris Hammes, Hans-Peter van Dijk, Marcory CRF Lexis, Chris PH van der Horst, Iwan CC Zeebregts, Clark J Vervloet, Marc G Wolffenbuttel, Bruce HR van Goor, Harry Hillebrands, Jan-Luuk |
| author_sort | van Ark, Joris |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3765479 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-37654792013-09-08 Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy van Ark, Joris Hammes, Hans-Peter van Dijk, Marcory CRF Lexis, Chris PH van der Horst, Iwan CC Zeebregts, Clark J Vervloet, Marc G Wolffenbuttel, Bruce HR van Goor, Harry Hillebrands, Jan-Luuk Cardiovasc Diabetol Correction BioMed Central 2013-08-28 /pmc/articles/PMC3765479/ http://dx.doi.org/10.1186/1475-2840-12-120 Text en Copyright © 2013 van Ark et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correction van Ark, Joris Hammes, Hans-Peter van Dijk, Marcory CRF Lexis, Chris PH van der Horst, Iwan CC Zeebregts, Clark J Vervloet, Marc G Wolffenbuttel, Bruce HR van Goor, Harry Hillebrands, Jan-Luuk Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy |
| title | Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy |
| title_full | Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy |
| title_fullStr | Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy |
| title_full_unstemmed | Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy |
| title_short | Correction: Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy |
| title_sort | correction: circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765479/ http://dx.doi.org/10.1186/1475-2840-12-120 |
| work_keys_str_mv | AT vanarkjoris correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT hammeshanspeter correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT vandijkmarcorycrf correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT lexischrisph correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT vanderhorstiwancc correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT zeebregtsclarkj correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT vervloetmarcg correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT wolffenbuttelbrucehr correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT vangoorharry correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy AT hillebrandsjanluuk correctioncirculatingalphaklotholevelsarenotdisturbedinpatientswithtype2diabeteswithandwithoutmacrovasculardiseaseintheabsenceofnephropathy |